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Abstract
Objective—To investigate the relationship between antioxidant nutrients (vitamins C and E, β-
carotene, selenium) and DNA methylation-related nutrients (folate, vitamins B6 and B12) and
distal colorectal cancer risk in whites and African Americans and to examine intakes from food
only versus total (food plus dietary supplements) intakes.
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Methods—Data are from the North Carolina Colon Cancer Study-Phase II, a case–control study
of 945 distal colorectal cancer (including sigmoid, rectosigmoid, and rectum) cases and 959
controls. In-person interviews captured usual dietary intake and various covariates. Multivariate
logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (95% CI).
Results—High intakes of each antioxidant and DNA methylation-related nutrient were
significantly associated with lower risk in whites. In African Americans, the highest category of
selenium from food only had a marginally significant inverse association with distal colorectal
cancer risk (Q4 vs. Q1 OR: 0.55, 95% CI 0.29–1.02). Supplements did not provide additional risk
reduction beyond intakes from food.
Conclusions—Our findings provide evidence that antioxidant and DNA methylation-related
nutrients may lower the risk of distal colorectal cancer in whites, and selenium may lower risk in
African Americans. Optimal micronutrient intakes from food alone may be more beneficial than
supplementation.
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Introduction
Colorectal cancer (CRC) is the third most common cancer in the United States [1] and
results from a combination of genetic, epigenetic, and environmental factors [2]. Diet is
widely believed to play an important role in the development of CRC, and several biological
mechanisms provide a theoretical link between micronutrients and reduced risk of CRC
[3,4].
Oxidative stress plays a major role in CRC development and progression [5] and results
from an excess production of free radicals or insufficient antioxidant defenses [6]. Free
radicals are unstable, highly reactive, oxygen-containing molecules that can cause tissue
damage. Therefore, the balance between free radicals and antioxidants is critical. Numerous
dietary nutrients, such as vitamin C, vitamin E, carotenoids, and selenium, have antioxidant
properties [4,7] and protect against the damaging effects of free radicals. In addition to their
antioxidant properties, these nutrients may also inhibit tumor development by stimulating
the immune system [8] and regulating cell growth [9]. Together, these properties of
antioxidant nutrients may help to prevent CRC.
Another well-known process involved in colorectal carcinogenesis is aberrant DNA
methylation, which includes global hypomethylation and hypermethylation of CpG islands
[10]. DNA hypomethylation, for example, is an early and consistently observed feature in
colorectal carcinogenesis [2,11]. It is a result of low levels of S-adenosyl methionine
(SAM), and the production of SAM depends on dietary factors such as folate, vitamin B6,
and vitamin B12. The main role of folate is to provide one-carbon units in several reactions
necessary for DNA methylation and synthesis, while vitamins B12 and B6 serve as cofactors
in some of these reactions [12]. Therefore, sustained low levels of these nutrients may lead
to disturbances in DNA methylation, synthesis, and repair, possibly influencing colorectal
carcinogenesis.
Despite the biological and mechanistic rationale for the hypothesis that these nutrients could
reduce the risk of CRC, epidemiological studies have yielded inconsistent results [13-16].
This may in part be due to different methods of diet assessment, or that few studies had
complete data on both dietary and supplemental sources of these nutrients. It is particularly
important to include intakes from vitamin and mineral supplements, as they contribute
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appreciably to micronutrient intakes [17]. Another reason could be that dietary risk factors
may differ for proximal and distal tumors in the colorectum. It has been suggested that diet
may have a greater influence on the development of distal colon tumors compared to
proximal colon tumors. Studies that examined the association between diet and sub-sites of
the colorectum reported stronger associations with distal colon cancer for fruits and
vegetables [18], alcohol [19], and calcium intake [20]. The different pH levels [21] and
bacterial composition [22] of these sites may affect their susceptibility to components of the
diet. Furthermore, proximal and distal colon tumors have different clinical features [23] and
genetic characteristics [24]. For example, methylation levels in normal mucosa of the
proximal and distal colon vary, which could contribute to the effect folate has on these sub-
sites [25]. The literature is scarce regarding the relationship between antioxidant and DNA
methylation-related nutrients and distal CRC specifically, particularly in African Americans.
In this report, we examined associations of selected micronutrients (from food only and food
plus dietary supplements) with risk of distal CRC among white and African American
participants. Specifically, we evaluated the relationships between antioxidant nutrients
(vitamin C, vitamin E, β-carotene, selenium) and DNA methylation-related nutrients (folate,




Data were obtained from the North Carolina Colon Cancer Study-Phase II, which was
conducted between May 2001 and September 2006. Subjects were eligible for the study if
they resided in one of 33 counties in central and eastern North Carolina, were African
American or White, were 40–79 years of age, had a North Carolina driver’s license, had no
previous diagnosis of colon or rectal cancer, and were able to give informed consent and
complete the interview. A randomized recruitment strategy was used to select cases and
controls [26]. African Americans were over-sampled to increase their representation in the
study. The recruitment probability for African American cases was 1.0 (i.e., all were
recruited) and African American controls had a higher recruitment probability than white
controls. This study was approved by the institutional review board at the University of
North Carolina-Chapel Hill.
Cases
Cases had a primary diagnosis of distal colorectal (including sigmoid, rectosigmoid, and
rectum) cancer during the study period. Cases were obtained from the rapid ascertainment
system of the North Carolina Central Cancer Registry and diagnoses were confirmed by our
study pathologist. Permission was received from the primary physician before contacting
cases. There were a total of 1,831 potentially eligible cases identified. Fifty-seven (3%) of
these were excluded for physician refusal, and 357 (19%) were found to be ineligible. Of the
remaining 1,417 eligible cases, 118 (8%) could not be contacted and 242 (17%) refused;
therefore, 1,057 (75%) had an in-person interview. On average, cases were interviewed
within 7 months after diagnosis. The overall response rate (number of persons interviewed
divided by the total number of eligible persons) for cases was 74% (76 and 70% for white
and African American cases, respectively).
Controls
Controls under the age of 65 were identified using lists provided by the North Carolina
Division of Motor Vehicles and the Center for Medicaid and Medicare Services for those 65
and older. Controls were selected using a randomized recruitment procedure based on
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sampling probabilities within blocks defined by 5-year age group, sex, and race [26]. There
were a total of 2,345 potentially eligible controls, but 518 (22%) were found to be ineligible.
Of the 1,827 eligible controls identified, 325 (18%) could not be contacted, 483 (26%)
refused to be contacted; therefore, 1,019 (56%) were interviewed. The overall response rate
for controls was 56% (58 and 46% for white and African American controls, respectively).
The analyses were restricted to those who completed all components of the study (n = 1987).
We further excluded 83 participants with implausible values for total energy intake (<800
kcal/day and >5,000 kcal/day for men and <600 kcal/day and >4,000 kcal/day for women)
[27]. Therefore, the analytic sample for this report included 1,520 whites (720 cases, 800
controls) and 384 African Americans (225 cases, 159 controls).
Data collection
Trained nurse-interviewers collected all data in participants’ home or another convenient
location using standard questionnaires. We collected information on age at diagnosis,
socioeconomic indicators, household information, physical activity, medical history, non-
steroidal anti-inflammatory drug use, smoking history, and first-degree family history of
colorectal cancer. Dietary information was obtained by an in-person interview using the
124-item Diet History Questionnaire (DHQ), which was developed and validated by the
National Cancer Institute [28–30]. The validation study was done in a nationally
representative sample and reported moderate to strong correlations with actual intake for
antioxidant nutrients such as vitamin C (r = 0.67 in men and 0.58 in women) and vitamin E
(r = 0.30 in men and 0.31 in women), and DNA methylation-related nutrients such as
vitamin B6 (r = 0.79 in men and 0.65 in women) [29]. In the present study, participants were
asked to recall their intake in the 12 months prior to diagnosis (cases) or interview
(controls). There were 10 frequency options for each food, as well as three choices to
estimate portion size. Nutrient and total energy intakes were based on the nutrient content of
each food item, frequency of consumption, and portion size, and were determined using
software provided by the NCI. The DHQ also collected detailed information on the type,
dose, and frequency of dietary supplement use. The nutrients of interest for this study were
antioxidant nutrients (vitamin C, vitamin E, β-carotene, selenium) and DNA methylation-
related nutrients (folate, vitamin B12, vitamin B6) from food and supplements.
Statistical analyses
All analyses were done using SAS 9.1 software (SAS Institute, Inc., Cary, NC). We
stratified the analyses by race and compared characteristics of cases and controls. We used
chi-square and Wilcoxon rank-sum tests to make these comparisons with regard to
categorical and continuous variables, respectively. Each nutrient was categorized into
quartiles based on sex-specific cutoffs in controls. Unconditional logistic regression models
were used to determine odds ratios (OR) and 95% confidence intervals (95% CI) for the
association between nutrient intake and risk of distal CRC. We examined these associations
for nutrient intake from foods only, as well as total intake (food plus dietary supplements).
Nutrients were examined in separate models. We also examined the relationship between
distal CRC risk and all antioxidant nutrients (i.e., the combined intakes of total vitamin C,
vitamin E, β-carotene, and selenium) and all DNA methylation-related nutrients (i.e., the
combined intakes of total folate, vitamin B6, and vitamin B12). All logistic models included
an offset term to adjust for the sampling probability. To assess confounding, the following
covariates were tested in a bivariate model with each nutrient: age (continuous), sex,
education (less than or equal to high school, some college, college graduate/advanced
degree), smoking status (never, current, former), prior BMI (i.e., in the year prior to
interview for controls and diagnosis for cases) (normal, overweight, obese), physical activity
(quartiles of metabolic equivalent (MET)-minutes/day), first-degree family history of
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colorectal cancer (yes, no), non-steroidal anti-inflammatory drug use (yes, no), and intakes
of alcohol (continuous), fiber (continuous), red meat (continuous), and fruit/vegetables
(continuous). Covariates that produced at least a 10% change in any of the nutrient
coefficients were considered potential confounders, and a backward-stepwise procedure was
done to obtain the final model. Any variable that was a confounder in any model was
retained in all models. We considered the other micronutrients as potential confounders,
although none met the criteria for confounding. All nutrients were adjusted for total energy
intake using the nutrient residual method [27], and all logistic regression models included
total energy as a covariate. A linear trend test was conducted using median quartile values
among controls, which were incorporated into the logistic regression model as a continuous
predictor. We assessed interactions with alcohol for each nutrient by including a cross-
product term in each model.
Results
Table 1 presents demographic and lifestyle characteristics of distal CRC cases and
respective controls stratified by race. In both whites and African Americans, cases were
slightly younger, had a higher mean BMI 1 year ago, and greater total daily energy intakes
than their respective controls. Fewer white cases reported using non-steroidal anti-
inflammatory drugs compared to controls (35.1 vs. 45.7%, p < 0.0001). In African
Americans, significantly more cases had a first-degree family history of CRC (p = 0.03). In
controls, a larger proportion of African Americans were obese and more whites were college
graduates.
Mean nutrient intakes for white and African American distal CRC cases and controls are
given in Table 2. Nutrient intake was evaluated by the contribution from food sources only
and from food and dietary supplements combined. There were significant differences in
intake between cases and controls in both racial groups. In general, white cases had lower
mean nutrient intakes than controls, while African American cases had higher nutrient
intakes than their respective controls. In both whites and African Americans, total (food plus
supplements) mean intakes for most nutrients were significantly different between cases and
controls (all p values <0.05). More specifically, white controls had higher intakes of all
nutrients, except selenium, compared to white cases; African American cases reported
higher consumption of vitamin C, vitamin E, folate, vitamin B6, and vitamin B12 than their
respective controls. The contribution of supplements to total selenium intake was negligible
in both racial groups. In controls, African Americans reported significantly lower total mean
intakes for most nutrients compared to whites, and the higher intakes in whites was mainly
due to contributions from dietary supplements. For example, daily vitamin E levels from
food sources only in white and African American controls were similar (12.0 mg αTE and
11.1 mg αTE, respectively); however, total vitamin E intake was 103 mg αTE among whites
and 47 mg αTE among African Americans.
Tables 3 and 4 give the associations (OR and 95% CI) between distal CRC and nutrients in
our study population, stratified by race. Table 3 presents results for antioxidant nutrients
(vitamins C and E, β-carotene, and selenium). In whites, the highest quartiles of all nutrients
were associated with a statistically significant lower risk of distal CRC compared to the
lowest quartile, except for total vitamin E intake. The greatest risk reduction was observed
for total β-carotene intake (Q4 vs. Q1 OR: 0.51, 95% CI 0.37–0.70). The ORs for the
highest categories of nutrient intake from food only and from total intake were similar for
vitamin C, β-carotene, and selenium. For example, the OR for high vitamin C intake from
food only was 0.58 (95% CI 0.42–0.80) and 0.59 (95% CI 0.43–0.80) for total vitamin C
intake. In whites, the statistically significant ORs of single antioxidant nutrients were
stronger than the OR for all antioxidant nutrients combined. In African Americans, high
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selenium intake from food had a marginally significant inverse association with distal CRC
risk (OR: 0.55, 95% CI 0.29–1.02), and moderately high intakes of total selenium was
significantly associated with lower risk (Q3 vs. Q1 OR: 0.45, 95% CI 0.24–0.87). There was
evidence of a linear trend for selenium intake from food only and total intake (ptrend = 0.02
and 0.04, respectively).
Table 4 gives results for DNA methylation-related nutrients (folate, vitamin B6, vitamin
B12). There were significantly lower risks of distal CRC associated with all DNA
methylation-related nutrients in whites when contrasting the highest and lowest quartiles of
intake, and all tests for linear trend were statistically significant. High intake of vitamin B6
from food in whites had the strongest (52%) reduction in risk (OR: 0.48, 95% CI 0.35–0.67,
ptrend < 0.0001). The OR for all DNA methylation-related nutrients combined was 0.57
(95% CI 0.41–0.80). In African Americans, the highest category of total folate, vitamin B6,
and vitamin B12, as well as all DNA methylation-related nutrients combined were
suggestive of elevated risk, although odds ratios were not statistically significant. However,
the trend analyses in African Americans were positive and statistically significant for total
folate (ptrend = 0.01) and total vitamin B6 (ptrend = 0.04).
We did not observe any statically significant interactions between alcohol intake and any of
the nutrients (data not shown). There was, however, a marginally significant interaction
between alcohol and folate from food only (p = 0.06).
Discussion
In this large population-based case–control study, each antioxidant nutrient was associated
with reduced distal CRC risk in whites, and there was an inverse trend in risk for selenium
intake in African Americans. Inverse associations with DNA methylation-related nutrients
were only observed in whites, and there were significant positive linear trends for total folate
and total vitamin B6 in African Americans.
There were notable differences in mean nutrient intakes between whites and African
Americans. In general, African American controls reported lower mean intakes than white
controls, primarily due to the greater contribution to intake from dietary supplements in
whites. The prevalence of any dietary supplement use in the last 12 months among our
control population was 72% in whites and 53% in African Americans. It has been estimated
that approximately 50–70% of non-institutionalized US adults take dietary supplements in
the form of multivitamin/mineral or singlenutrient supplements [17,31], and Radimer et al.
[17] also noted that supplement use patterns differ by race. Therefore, it is necessary to
collect detailed information on supplement use when assessing the effect of micronutrients
on disease risk, especially in racially diverse populations.
Findings in this present study for whites are consistent with the hypotheses that dietary
antioxidants may reduce the risk of distal CRC. Our results are in agreement with other
observational studies reporting significant inverse associations for dietary antioxidant intake
and colon [32-35] and rectal cancer [33]. Kune and colleagues reported colon and rectal
cancer risk reductions for high intakes of vitamin C, vitamin E, and selenium [33], and
elevated risk of rectal cancer has been observed for low vitamin E intakes in women [36].
On the contrary, there was no effect of vitamin E on colon cancer in the Women’s Health
Study clinical trial [37], and a large population-based case–control study reported no
association between β-carotene intake and proximal or distal colon cancer [38]. Most of the
current evidence has been limited to non-African American populations; however, in a
previous case–control study Satia-Abouta et al. noted significant inverse associations with
colon cancer for high intakes of β-carotene, vitamin C, and vitamin E in African Americans
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[34]. We did not observe any statistically significant risk estimates for antioxidant nutrients
in African Americans in the present study.
We also found intakes of DNA methylation-related nutrients to be associated with reduced
risk of distal CRC in whites. Results are conflicting regarding the effect of folate on CRC
development. In a recent report of the Netherlands Cohort Study, the authors did not find
folate to be significantly associated with CRC risk in men or women [39]. Null findings
have also been reported for folate and colon cancer [34,40-42]. The most recent report from
the World Cancer Research Fund/American Institute for Cancer Research indicated that
there is only limited suggestive evidence that folate reduces the risk of CRC [43].
Epidemiologic studies of vitamin B6 and B12 are limited in comparison with studies on
folate intake. The present study is in agreement with findings from an Australian case–
control study in which there was a statistically significant lower risk of colon and rectal
cancer for the highest categories of vitamin B6 and B12 intake [33]. On the other hand, two
large prospective studies observed an elevated risk of rectal cancer in women for high intake
of vitamin B6 [39,41]. These discrepant findings may be due to inherent biases in case–
control studies, the method of dietary assessment, or variation in intakes of these
micronutrients. We did not observe interactions with alcohol for any of these DNA
methylation-related nutrients, although alcohol is a known to interact with these nutrients
[44]. This may be because the average alcohol intake in our study population (8 g/day) was
much lower than the level at which alcohol intake has been shown to be associated with
elevated CRC risk (≥30 g/day) [19].
The reasons why the associations between micronutrients and distal CRC differ for whites
and African Americans are not totally clear. Surprisingly, the odds ratios for high total
intakes of vitamin C and all DNA methylation-related nutrients suggested elevated risk of
distal CRC in African Americans, although they were not significant. This direct association
may be due to the source of these nutrients; however, after controlling for fruit and
vegetable consumption there was still a non-significant positive association with risk. Due to
our small sample of African Americans, we may have missed other statistically significant
associations, and this small sample size may also have led to unstable estimates. We did,
however, observe a significant inverse trend for selenium, and positive trends for total folate
and total vitamin B6. Results from other epidemiologic studies with adequate African
American representation are needed to confirm (or dispute) these findings.
It is interesting to note that for all DNA methylation-related nutrients and vitamin E in
whites, the risk reduction was greater for intake from food sources only compared to total
intake (food plus supplements). Other studies have reported null effects of supplement use
on colorectal cancer [45,46] and adenomas [47,48]. For example, compared to the placebo, 1
mg/day of folic acid did not reduce the risk of colorectal adenomas, the precursor to colon
and rectal cancer, and actually increased the risk of advanced adenomas in the Aspirin/
Folate Polyp Prevention Study [48]. There are several possible explanations for these
findings. One reason may relate to the dual effect of folate, depending on dosage and time of
exposure. While adequate folate intake may suppress tumor development, excessive intake
may not offer additional benefit or even enhance carcinogenesis, especially when there are
pre-existing lesions [49]. These disparate findings may also reflect the different chemical
structures and biological pathways of natural folate and synthetic folic acid. Folic acid is
more bioavailable and therefore more readily absorbed than natural folate found in food
[50]. However, high circulating levels of unmetabolized folic acid may reduce the immune
response against carcinogenic cells by reducing the amount of natural killer cells [50]. When
considering intake from foods versus supplements, it is important to note that foods can
contain the synthetic form of the nutrient due to fortification. For example, mandatory
fortification in the United States resulted in an average total folate intake of approximately
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400 μg/day among supplement non-users, with only about 200 μg/day being naturally
occurring folate and 200 μg/day being folic acid in fortified foods [51,52].
Clinical trials have also found no evidence for associations of vitamin C, vitamin E, or β-
carotene with reduced risk of CRC [45,46]. One trial reported a significant inverse
association of vitamin E supplementation and colon cancer risk, but there was no
statistically significant association with rectal cancer [46]. Therefore, these supplements
may have different effects on proximal and distal sites in the colon. Also, at high
concentrations, vitamins C and E may exert pro-oxidant effects, and thereby promote
oxidative DNA damage. Our study results suggest that nutrient intake from dietary
supplements may not help reduce distal CRC risk, and that intake from food sources alone
may be more relevant for risk reduction. This could be because supplement use may only
benefit those with suboptimal nutrient intakes, while providing no benefit for those with
adequate intakes. In our study, the mean intake of these micronutrients from food alone in
whites and African Americans was above the daily recommended intakes [53]. In addition,
other compounds of natural foods such as phytochemicals and fiber may be
chemopreventive and act in synergy with these nutrients to reduce distal CRC risk, and it is
likely that past and long-term supplement use may be associated with risk as opposed to
recent use. Currently, the overall evidence for recommending supplements for CRC is weak
[54].
A major strength of this study was our large sample size, especially for a study of distal
colorectal cancer. This allowed us to observe associations that would be undetectable in
studies with fewer participants. All data were collected in-person by trained nurse-
interviewers, thereby minimizing the potential for misclassification. We collected detailed
information on dietary supplement use to include in our assessment of total nutrient intake.
Our study is among the first reports of micronutrient intake and distal CRC risk in African
Americans.
There are some limitations worth noting. Our study was subject to potential biases in case–
control studies such as recall bias. It is possible that there was differential recall between
cases and controls. Differential response rates between cases and controls, as well as
between whites and African Americans, could have biased our results. There was also the
potential of measurement error; however, the diet history questionnaire has been validated
[29,30], although not in African American populations. We cannot exclude the possibility of
chance findings due to multiple testing and the possibility of residual confounding.
In summary, the present findings add to the evidence that dietary antioxidants (vitamin C,
vitamin E, β-carotene, selenium) and DNA methylation-related nutrients (folate, vitamin B6,
vitamin B12) are associated with lower risk of distal colorectal cancer in whites. Our results
also support the hypotheses of mechanisms by which these nutrients may play a role in
preventing colorectal cancer. Our findings suggest that the associations between these
nutrients and distal colorectal cancer may differ between whites and African Americans.
This stresses the importance of examining these associations by race in large racially diverse
samples. Furthermore, intakes from dietary supplements appeared to attenuate the risk
reduction in whites for some nutrients, suggesting that optimal intakes of these nutrients
from food sources alone may be sufficient to lower risk of distal colorectal cancer.
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